Open in app

Four Indian-made cough syrups are under scrutiny; CDSCO launches an investigation in response to WHO red flags.

Total Views:
Total Likes:
Published By:
Peeyush Ghalot
Published On:
(Photo Courtesy: - Fortune India)

The government has opened an investigation into four cough syrups produced by a pharmaceutical company with its headquarters in Haryana. The WHO has been asked to provide with CDSCO (Central Drugs Standard Control Organization) as soon as possible the report on the establishment of a causal relation to the fatalities with the in question medical items, images of labels/products, etc., even though all necessary procedures will be performed. The investigation was started in response to a warning from the World Health Organization that four cough syrups made by Maiden Pharmaceuticals Limited, a company situated in Sonipat, Haryana, may have been the source of deaths in the country of West Africa. The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Make off Baby Cough Syrup, and Magrip N Cold Syrup, according to the WHO advisory. The alert stated that laboratory analysis of product samples has confirmed that they contain unacceptable levels of diethylene glycol and ethylene glycol as contaminants. It also stated that the stated manufacturer has not, to date, given WHO guarantees regarding the safety and quality of these products. WHO has not yet published the specific one to one causal relationship of mortality. Additionally, they mentioned that the WHO has not yet made information and pictures of labels attesting to the producers of the products public.

Reference: -